Literature DB >> 21360563

hZIP1 zinc transporter down-regulation in prostate cancer involves the overexpression of ras responsive element binding protein-1 (RREB-1).

Jing Zou1, Beatrice C Milon, Mohamed M Desouki, Leslie C Costello, Renty B Franklin.   

Abstract

BACKGROUND: A marked decrease in the level of zinc is a consistent characteristic of prostate cancer; which results from down-regulation of ZIP1 zinc transporter. The aim of this study was to determine if RREB-1 transcription is involved in the down-regulation of ZIP1 gene expression; and to determine the expression of RREB-1 in benign and cancerous prostate in situ.
METHODS: Overexpression and siRNA knock down of RREB-1 were used to determine the effect of RREB-1 on hZIP1 abundance in PC-3 cells. Immunohistochemistry with tissue microarrays (TMAs) and tissue sections was used to determine the levels of RREB-1 expression in prostate in situ.
RESULTS: Overexpression of RREB-1 resulted in a decrease in the abundance of hZIP1 in the plasma membrane of PC-3 cells; whereas siRNA knock down significantly increased hZIP1 expression. Prostate TMAs and tissue sections showed an inverse relationship between RREB-1 and hZIP1 staining.
CONCLUSIONS: RREB-1 overexpression results in down-regulation of hZIP1 and contributes to the loss of hZIP1 expression and zinc in prostate cancer. This is an early event in prostate carcinogenesis.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Keywords:  RREB-1; hZIP1; prostate cancer; zinc transporter

Mesh:

Substances:

Year:  2011        PMID: 21360563      PMCID: PMC3116060          DOI: 10.1002/pros.21368

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  32 in total

1.  Differential subcellular localization of hZip1 in adherent and non-adherent cells.

Authors:  B Milon; D Dhermy; D Pountney; M Bourgeois; C Beaumont
Journal:  FEBS Lett       Date:  2001-11-02       Impact factor: 4.124

2.  Differential zinc accumulation and expression of human zinc transporter 1 (hZIP1) in prostate glands.

Authors:  Leslie A Johnson; Mazhar A Kanak; Andre' Kajdacsy-Balla; Joseph P Pestaner; Omar Bagasra
Journal:  Methods       Date:  2010-08-10       Impact factor: 3.608

3.  Protein kinase C alpha, epsilon and AP-1 mediate prolactin regulation of mitochondrial aspartate aminotransferase expression in the rat lateral prostate.

Authors:  R B Franklin; J Zou; J Ma; L C Costello
Journal:  Mol Cell Endocrinol       Date:  2000-12-22       Impact factor: 4.102

4.  Terminal oxidation and the effects of zinc in prostate versus liver mitochondria.

Authors:  Leslie C Costello; Zhixin Guan; Boone Kukoyi; Pei Feng; Renty B Franklin
Journal:  Mitochondrion       Date:  2004-08       Impact factor: 4.160

Review 5.  Signal transduction in prostate cancer progression.

Authors:  Daniel Gioeli
Journal:  Clin Sci (Lond)       Date:  2005-04       Impact factor: 6.124

Review 6.  Ras signaling in prostate cancer progression.

Authors:  Michael J Weber; Daniel Gioeli
Journal:  J Cell Biochem       Date:  2004-01-01       Impact factor: 4.429

7.  RREB-1, a novel zinc finger protein, is involved in the differentiation response to Ras in human medullary thyroid carcinomas.

Authors:  A Thiagalingam; A De Bustros; M Borges; R Jasti; D Compton; L Diamond; M Mabry; D W Ball; S B Baylin; B D Nelkin
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

8.  Human ZIP1 is a major zinc uptake transporter for the accumulation of zinc in prostate cells.

Authors:  R B Franklin; J Ma; J Zou; Z Guan; B I Kukoyi; P Feng; L C Costello
Journal:  J Inorg Biochem       Date:  2003-08-01       Impact factor: 4.155

9.  Prostate cancer in African American men is associated with downregulation of zinc transporters.

Authors:  Irum Rishi; Hasna Baidouri; Jamil A Abbasi; Rebecca Bullard-Dillard; Andre' Kajdacsy-Balla; Joseph P Pestaner; Marek Skacel; Raymond Tubbs; Omar Bagasra
Journal:  Appl Immunohistochem Mol Morphol       Date:  2003-09

10.  Cation diffusion facilitator proteins modulate Raf-1 activity.

Authors:  Tanawat Jirakulaporn; Anthony J Muslin
Journal:  J Biol Chem       Date:  2004-04-19       Impact factor: 5.157

View more
  21 in total

1.  GAS5 functions as a ceRNA to regulate hZIP1 expression by sponging miR-223 in clear cell renal cell carcinoma.

Authors:  Xiao Dong; Chuize Kong; Xiankui Liu; Jianbin Bi; Zhenhua Li; Zeliang Li; Yuyan Zhu; Zhe Zhang
Journal:  Am J Cancer Res       Date:  2018-08-01       Impact factor: 6.166

2.  Evidence for changes in RREB-1, ZIP3, and Zinc in the early development of pancreatic adenocarcinoma.

Authors:  Leslie C Costello; Jing Zou; Mohamed Mokhtar Desouki; Renty B Franklin
Journal:  J Gastrointest Cancer       Date:  2012-12

Review 3.  A comprehensive review of the role of zinc in normal prostate function and metabolism; and its implications in prostate cancer.

Authors:  Leslie C Costello; Renty B Franklin
Journal:  Arch Biochem Biophys       Date:  2016-04-27       Impact factor: 4.013

4.  Resveratrol-zinc combination for prostate cancer management.

Authors:  Chandra K Singh; Anna Pitschmann; Nihal Ahmad
Journal:  Cell Cycle       Date:  2014-05-27       Impact factor: 4.534

5.  The gep proto-oncogene Gα12 mediates LPA-stimulated activation of CREB in ovarian cancer cells.

Authors:  Ji Hee Ha; Jeremy D Ward; Lakshmi Varadarajalu; Sang Geon Kim; Danny N Dhanasekaran
Journal:  Cell Signal       Date:  2013-09-19       Impact factor: 4.315

Review 6.  Development of Zinc-Specific iCEST MRI as an Imaging Biomarker for Prostate Cancer.

Authors:  Yue Yuan; Zhiliang Wei; Chengyan Chu; Jia Zhang; Xiaolei Song; Piotr Walczak; Jeff W M Bulte
Journal:  Angew Chem Int Ed Engl       Date:  2019-09-17       Impact factor: 15.336

Review 7.  Zinc and zinc transporters in prostate carcinogenesis.

Authors:  Vladimir Kolenko; Ervin Teper; Alexander Kutikov; Robert Uzzo
Journal:  Nat Rev Urol       Date:  2013-03-12       Impact factor: 14.432

8.  A Review of the Current Status and Concept of the Emerging Implications of Zinc and Zinc Transporters in the Development of Pancreatic Cancer.

Authors:  Leslie C Costello; Renty B Franklin
Journal:  Pancreat Disord Ther       Date:  2013

9.  CtBP and associated LSD1 are required for transcriptional activation by NeuroD1 in gastrointestinal endocrine cells.

Authors:  Subir K Ray; H Joyce Li; Eric Metzger; Roland Schüle; Andrew B Leiter
Journal:  Mol Cell Biol       Date:  2014-04-14       Impact factor: 4.272

Review 10.  SLC transporters as a novel class of tumour suppressors: identity, function and molecular mechanisms.

Authors:  Yangzom D Bhutia; Ellappan Babu; Sabarish Ramachandran; Shengping Yang; Muthusamy Thangaraju; Vadivel Ganapathy
Journal:  Biochem J       Date:  2016-05-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.